Thrivable 365 is a syndicated patient research program for pharma commercial teams competing in the GLP-1 and cardiometabolic market, delivered four times a year. Each report combines a quantitative survey, a discrete-choice conjoint, and 1,000+ audio-recorded patient responses into a single 30–40 page narrative, so you see not just what patients are doing, but why.
